Cargando…

Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis

Parkinson’s disease (PD) is a neurodegenerative disease characterized by progressive degeneration of dopaminergic neurons, and at the cellular level by the formation of Lewy bodies in the central nervous system (CNS). However, the onset of the disease is believed to be localized to peripheral organs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harsanyiova, Jana, Buday, Tomas, Kralova Trancikova, Alzbeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313629/ https://www.ncbi.nlm.nih.gov/pubmed/32625058 http://dx.doi.org/10.3389/fnins.2020.00626

Ejemplares similares

Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
por: Fricova, Dominika, et al.
Publicado: (2020)

The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders
por: Pokusa, Michal, et al.
Publicado: (2017)

Extracellular DNA Correlates with Intestinal Inflammation in Chemically Induced Colitis in Mice
por: Maronek, Martin, et al.
Publicado: (2021)

Immunodetection of Pyruvate Carboxylase Expression in Human Astrocytomas, Glioblastomas, Oligodendrogliomas, and Meningiomas
por: Gondáš, Eduard, et al.
Publicado: (2023)

GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1
por: Stafa, Klodjan, et al.
Publicado: (2012)

Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism
por: Podhajska, Agata, et al.
Publicado: (2012)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Expression of 3-Methylcrotonyl-CoA Carboxylase in Brain Tumors and Capability to Catabolize Leucine by Human Neural Cancer Cells
por: Gondáš, Eduard, et al.
Publicado: (2022)

Parkinson Disease: An Evolutionary Perspective
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2017)

Analysis of the Gut Microflora in Patients With Parkinson's Disease
por: Jin, Miao, et al.
Publicado: (2019)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017)

Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease
por: Greenbaum, Lior, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Will Crystal Parkin Help in Understanding the Future of Parkinson’s Disease?
por: Olszewska, Diana Angelika, et al.
Publicado: (2015)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

Deep Brain Stimulation to Alleviate Freezing of Gait and Cognitive Dysfunction in Parkinson's Disease: Update on Current Research and Future Perspectives
por: Huang, Chuyi, et al.
Publicado: (2018)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
por: Lubomski, Michal, et al.
Publicado: (2022)

Circulating CircRNAs Panel Acts as a Biomarker for the Early Diagnosis and Severity of Parkinson’s Disease
por: Zhong, Lingling, et al.
Publicado: (2021)

Centrality of Early Synaptopathy in Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2018)

The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
por: Hipp, Geraldine, et al.
Publicado: (2018)

Editorial: New challenges and future perspectives in neurodegeneration
por: Li, Zhenyu, et al.
Publicado: (2022)

The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis
por: Shen, Ting, et al.
Publicado: (2021)

What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson’s Disease?
por: Hill, Amaryllis E., et al.
Publicado: (2021)

The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
por: Klann, Emily M., et al.
Publicado: (2022)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

Identification of gut metabolites associated with Parkinson’s disease using bioinformatic analyses
por: Yan, Jun, et al.
Publicado: (2022)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson’s Disease
por: Huang, Huan-jie, et al.
Publicado: (2018)

Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective
por: Jena, Ankita, et al.
Publicado: (2020)

Parkinson's Disease: General Features, Effects of Levodopa Treatment and Future Directions
por: Freire, Marco Aurélio M., et al.
Publicado: (2010)

Enteric glia as a player of gut-brain interactions during Parkinson’s disease
por: Thomasi, Beatriz, et al.
Publicado: (2023)

Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease
por: Cabezas, Ricardo, et al.
Publicado: (2014)

Associations between Early Markers of Parkinson's Disease and Sarcopenia
por: Drey, Michael, et al.
Publicado: (2017)

Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson’s Disease
por: de Celis Alonso, Benito, et al.
Publicado: (2015)

Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature
por: Mei, Jie, et al.
Publicado: (2021)

Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
por: Ma, Kai, et al.
Publicado: (2018)

Back to the future: lessons from past viral infections and the link with Parkinson’s disease
por: Dowd, Eilis, et al.
Publicado: (2021)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
por: Chen, Tian-Jiao, et al.
Publicado: (2020)

Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
por: Li, Chunxiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lbh3ggks4ftckhkuhjjse0c5op